Researchers developed an epitope editing strategy to make donated stem cells invisible to pre-transplant antibody therapy, offering up a new approach that could make antibodies a less toxic alternative to chemotherapy for selectively clearing the patient’s existing stem cells from the bone marrow. The post Epitope Editing Strategy Could Enable Less Toxic Stem Cell Transplants appeared first on GEN -…
You may also like
Pluripotent stem cell trial for Huntington’s disease
Jascayd gains UK licence for treatment of pulmonary...
Medical-Commercial alignment in rare disease launches:...
Engineered AAVs Harness Glymphatic System to Reach...
Ag Genomics Begins to Bear Fruit
Top 10 Best-Selling Drugs 2026
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
